DUBLIN, November 17, 2017 /PRNewswire/ -- The "Therapies for Resistant and Recurrent Metastatic Cancer" report has been added to Research and Markets' offering. The Global Cancer Therapeutics Market Should Reach $172.6 Billion by 2022 from $121 Billion in 2017 at a CAGR of 7.4%...
from PR Newswire: //www.prnewswire.co.uk/news-releases/global-1726-billion-therapies-market-for-resistant-and-recurrent-metastatic-cancer-2022-658189713.html
No comments:
Post a Comment